BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jewett A, Kos J, Kaur K, Safaei T, Sutanto C, Chen W, Wong P, Namagerdi AK, Fang C, Fong Y, Ko MW. Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis. Mol Ther Oncolytics 2020;16:41-52. [PMID: 31930165 DOI: 10.1016/j.omto.2019.11.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu Z, Xu X, Wei H. The Adverse Impact of Tumor Microenvironment on NK-Cell. Front Immunol 2021;12:633361. [PMID: 34177887 DOI: 10.3389/fimmu.2021.633361] [Reference Citation Analysis]
2 Kaur K, Vaziri S, Romero-Reyes M, Paranjpe A, Jewett A. Phenotypic and Functional Alterations of Immune Effectors in Periodontitis; A Multifactorial and Complex Oral Disease. J Clin Med 2021;10:875. [PMID: 33672708 DOI: 10.3390/jcm10040875] [Reference Citation Analysis]
3 Burster T, Gärtner F, Bulach C, Zhanapiya A, Gihring A, Knippschild U. Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells. Pharmaceuticals (Basel) 2021;14:236. [PMID: 33800301 DOI: 10.3390/ph14030236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ma Y, Ou J, Lin T, Chen L, Wang J, Qiao D, Lai S, Duan C, Cheng Y, Chang R, Zhang C, Wang M. Phenotypic analysis of tumor-infiltrating lymphocytes from non-small cell lung cancer and their potential application for adoptive cell therapy. Immunopharmacol Immunotoxicol 2020;42:319-29. [PMID: 32419542 DOI: 10.1080/08923973.2020.1765375] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ko M, Kaur K, Safaei T, Chen W, Sutanto C, Wong P, Jewett A. Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes. Cells 2022;11:697. [DOI: 10.3390/cells11040697] [Reference Citation Analysis]
6 Breznik B, Ko MW, Tse C, Chen PC, Senjor E, Majc B, Habič A, Angelillis N, Novak M, Župunski V, Mlakar J, Nathanson D, Jewett A. Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres. Commun Biol 2022;5:436. [PMID: 35538218 DOI: 10.1038/s42003-022-03402-z] [Reference Citation Analysis]
7 Duan XC, Peng LY, Yao X, Xu MQ, Li H, Zhang SQ, Li ZY, Wang JR, Feng ZH, Wang GX, Liao A, Chen Y, Zhang X. The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death. Drug Deliv 2021;28:800-13. [PMID: 33866918 DOI: 10.1080/10717544.2021.1909180] [Reference Citation Analysis]
8 Donini C, Rotolo R, Proment A, Aglietta M, Sangiolo D, Leuci V. Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective. Cells 2021;10:543. [PMID: 33806296 DOI: 10.3390/cells10030543] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Jewett A. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions. Front Immunol 2020;11:1692. [PMID: 32754162 DOI: 10.3389/fimmu.2020.01692] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
10 Zhang K, Roy NK, Vicioso Y, Woo J, Beck R, de Lima M, Caimi P, Feinberg D, Parameswaran R. BAFF receptor antibody for mantle cell lymphoma therapy. Oncoimmunology 2021;10:1893501. [PMID: 33747637 DOI: 10.1080/2162402X.2021.1893501] [Reference Citation Analysis]
11 Villa NY, Rahman MM, Mamola J, D'Isabella J, Goras E, Kilbourne J, Lowe K, Daggett-Vondras J, Torres L, Christie J, Appel N, Cox AL, Kim JB, McFadden G. Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma. Mol Ther Oncolytics 2020;18:171-88. [PMID: 32695875 DOI: 10.1016/j.omto.2020.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Qian Y, Gong Y, Fan Z, Luo G, Huang Q, Deng S, Cheng H, Jin K, Ni Q, Yu X, Liu C. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. J Hematol Oncol 2020;13:130. [PMID: 33008426 DOI: 10.1186/s13045-020-00958-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
13 Marín-Jiménez JA, Capasso A, Lewis MS, Bagby SM, Hartman SJ, Shulman J, Navarro NM, Yu H, Rivard CJ, Wang X, Barkow JC, Geng D, Kar A, Yingst A, Tufa DM, Dolan JT, Blatchford PJ, Freed BM, Torres RM, Davila E, Slansky JE, Pelanda R, Eckhardt SG, Messersmith WA, Diamond JR, Lieu CH, Verneris MR, Wang JH, Kiseljak-Vassiliades K, Pitts TM, Lang J. Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes. Front Immunol 2021;12:607282. [PMID: 33854497 DOI: 10.3389/fimmu.2021.607282] [Reference Citation Analysis]
14 Patrizi O, Rampinelli F, Coltrini D, Pesce S, Carlomagno S, Sivori S, Pascale A, Marcenaro E, Parolini S, Tabellini G. Natural killer cell impairment in ovarian clear cell carcinoma. J Leukoc Biol 2020;108:1425-34. [PMID: 32794325 DOI: 10.1002/JLB.5MA0720-295R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Maharaj D, Srinivasan G, Abreu MM, Ko MW, Jewett A, Gouvea J. Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV- Unmutated Chronic Lymphocytic Leukemia. Cells 2020;10:E10. [PMID: 33375215 DOI: 10.3390/cells10010010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Perera Molligoda Arachchige AS. Human NK cells: From development to effector functions. Innate Immun 2021;27:212-29. [PMID: 33761782 DOI: 10.1177/17534259211001512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Chhabra G, Singh CK, Amiri D, Akula N, Ahmad N. Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment. Molecules 2021;26:1343. [PMID: 33802331 DOI: 10.3390/molecules26051343] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Medda A, Duca D, Chiocca S. Human Papillomavirus and Cellular Pathways: Hits and Targets. Pathogens 2021;10:262. [PMID: 33668730 DOI: 10.3390/pathogens10030262] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wang H, Chen X, Chen Y, Cao Y, Chen Y, Liu G, Huang L. [ENTPD5 gene is highly expressed in epithelial ovarian cancer: analysis based on Oncomine database and bioinformatics]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:555-61. [PMID: 33963715 DOI: 10.12122/j.issn.1673-4254.2021.04.11] [Reference Citation Analysis]